Publications by authors named "Erica Lyons"

Claim this Profile
S
Severe gastrointestinal adverse reactions including perforation, ulceration, hemorrhage, and obstruction: A fumaric acid ester class new safety risk.
Tiffany Kim, Allen Brinker, David Croteau, Paul R Lee, Laura E Baldassari, Erica Lyons

Mult Scler· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Because of this rotation, this is what I want to do": Implementation and evaluation of a telehealth opioid use disorder clinical placement for nurse practitioner students.
Rachel French, Erica Lyons, Allison Schachter, June A Treston, Ami Marshall

J Am Assoc Nurse Pract· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare disease variant curation from literature: assessing gaps with creatine transport deficiency in focus.
Erica L Lyons, Daniel Watson, Mohammad S Alodadi, Sharie J Haugabook, Gregory J Tawa

BMC Genomics· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Trials in Pancreatitis: Opportunities and Challenges in the Design and Conduct of Patient-Focused Clinical Trials in Recurrent Acute and Chronic Pancreatitis: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.
Phil A Hart, Dana K Andersen, Erica Lyons, Gregory A Cote, Zobeida Cruz-Monserrate

Pancreas· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcome Assessments in Gastrointestinal Clinical Trials: A Framework for Development and Validation.
Christopher O St Clair, Sarrit M Kovacs, Erica M Lyons, Jessica J Lee

Am J Gastroenterol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing Drugs for Prevention of Chemotherapy-Induced Nausea and Vomiting: Draft Guidance from the FDA.
Erica Lyons, Charles Line, Jessica J Lee

Clin Cancer Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review article: the evolution of endpoint assessments for chemotherapy-induced nausea and vomiting and post-operative nausea and vomiting-a perspective from the US Food and Drug Administration.
Maegan E Gabby, Kevin Bugin, Erica Lyons

Aliment Pharmacol Ther· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabinoid receptor subtype influence on neuritogenesis in human SH-SY5Y cells.
Erica L Lyons, Sandra Leone-Kabler, Alexander L Kovach, Brian F Thomas, Allyn C Howlett

Mol Cell Neurosci· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing Pharmacologic Treatments for Eosinophilic Esophagitis: Draft Guidance from the United States Food and Drug Administration.
Erica Lyons, Kathleen Donohue, Jessica J Lee

Gastroenterology· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabinoid receptor interacting protein suppresses agonist-driven CB receptor internalization and regulates receptor replenishment in an agonist-biased manner.
Lawrence C Blume, Sandra Leone-Kabler, Deborah J Luessen, Glen S Marrs, Erica Lyons

J Neurochem· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Procollagen C-endopeptidase Enhancer Protein 2 (PCPE2) Reduces Atherosclerosis in Mice by Enhancing Scavenger Receptor Class B1 (SR-BI)-mediated High-density Lipoprotein (HDL)-Cholesteryl Ester Uptake.
Ricquita D Pollard, Christopher N Blesso, Manal Zabalawi, Brian Fulp, Mark Gerelus, Erica W Lyons

J Biol Chem· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis